SCHEMBL25848392

SCHEMBL25848392

C=CC(=O)OCC(C)(C)COc1ccc2cc(-c3ccc(OCCCC)cc3)c(=O)oc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.50
TP53 P04637 1/20 0.49
NPC1 O15118 8/20 0.48
RAB9A P51151 8/20 0.48
KDM4E B2RXH2 3/20 0.48
GLA P06280 3/20 0.48
ALDH1A1 P00352 2/20 0.48
GAA P10253 2/20 0.48
HPGD P15428 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 1/20 0.48
PKM P14618 1/20 0.48
MAPK1 P28482 1/20 0.48
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
MAOA P21397 1/20 0.46
POLB P06746 1/20 0.46
RECQL P46063 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625406 0.90 TP53 (0.46) MAOBTP53NPC1RAB9AKDM4E
SCHEMBL25848175 0.89 NPC1 (0.60) MAOBNPC1RAB9AKDM4EGLA
SCHEMBL18535503 0.89 NPC1 (0.53) MAOBTP53NPC1RAB9AKDM4E
SCHEMBL22625283 0.86 MAOB (0.58) MAOBTP53NPC1RAB9AKDM4E
SCHEMBL25848177 0.83 RAB9A (0.46) MAOBTP53NPC1RAB9AKDM4E
SCHEMBL25848180 0.82 THRB (0.42) MAOBTP53NPC1RAB9AKDM4E
SCHEMBL25848185 0.82 THRB (0.42) MAOBTP53NPC1RAB9AKDM4E
SCHEMBL24055239 0.81 MAOB (0.52) MAOBTP53NPC1RAB9AKDM4E
SCHEMBL18535504 0.81 TP53 (0.48) MAOBTP53NPC1RAB9AKDM4E
SCHEMBL25848189 0.81 THRB (0.41) MAOBNPC1RAB9AKDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 MAOB 3207/4885TP53 2457/4885NPC1 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.